PATENT CLAIM ANALYSIS

Application Number: 16083879
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["549", "023000"]

Abstract:
Disclosed are a retinoid compound, a preparation method therefor, intermediates thereof and an application thereof. The retinoid compound I of the present invention has a good tumor growth inhibition rate.

Claim (Index 10):
A method for treating a patient in need of a medicament for treating a primary tumor, comprising administering to the patient a medicament comprising an effective amount of the compound represented by formula I, the enantiomer, the diastereomer or the pharmaceutically acceptable salt thereof as defined in  claim 1 .

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.25926
- Patent Class: 549.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15025618', '12780132', '15999075', '13302409', '12524545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7545857326403723
- 35 USC 102 Novelty (BERT): 0.514317812294507
- Combined Prediction Score: 0.7305589406057857
- Mean Citation Score: 315.0832680000001
- Max Citation Score: 317.32526
- Similarity Product: 253.0155477181017

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test